Medications for Colonic Neoplasms
24 results
Avastin (bevacizumab)
(bevacizumab)Genentech, Inc.
Usage: Avastin is indicated for the treatment of various cancers, including metastatic colorectal cancer (in combination with chemotherapy), non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, cervical cancer, and advanced ovarian cancers (both sensitive and resistant). Additionally, it is used for unresectable hepatocellular carcinoma.
Braftovi (encorafenib)
(Encorafenib)Array BioPharma Inc.
Usage: BRAFTOVI is indicated for the treatment of unresectable or metastatic melanoma, metastatic colorectal cancer (mCRC), and metastatic non-small cell lung cancer (NSCLC) with BRAF V600E or V600K mutations when used with specific combinations. It is not meant for wild-type BRAF tumors.
Capecitabine (capecitabine)
(capecitabine)BluePoint Laboratories
Usage: Capecitabine is indicated for the treatment of various cancers, including Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, and unresectable or metastatic gastric and pancreatic cancers, often in combination with other chemotherapy agents.
Capecitabine (capecitabine)
(Capecitabine)Aurobindo Pharma Limited
Usage: Capecitabine tablets are indicated for the treatment of Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, unresectable gastric or esophageal cancers, and as adjuvant therapy for pancreatic adenocarcinoma in combination with chemotherapy regimens.
Fluorouracil (fluorouracil)
(FLUOROURACIL)Eugia US LLC
Usage: Fluorouracil injection is indicated for treating patients with adenocarcinoma of the colon and rectum, breast, stomach, and pancreas.
Fruzaqla (fruquintinib)
(fruquintinib)Takeda Pharmaceuticals America, Inc.
Usage: FRUZAQLA is indicated for adult patients with metastatic colorectal cancer (mCRC) previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, anti-VEGF therapy, and, if RAS wild-type, an anti-EGFR therapy.
Irinotecan hydrochloride (irinotecan hydrochloride)
(Irinotecan Hydrochloride)Hikma Pharmaceuticals USA Inc.
Usage: Irinotecan Hydrochloride Injection is indicated for patients with metastatic colon or rectal carcinoma that has recurred or progressed after initial treatment with fluorouracil-based therapy.
Krazati (adagrasib)
(adagrasib)Mirati Therapeutics, Inc
Usage: KRAZATI is indicated for adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received prior therapy, and for KRAS G12C-mutated locally advanced or metastatic colorectal cancer (CRC) in combination with cetuximab after specific chemotherapy treatments.
Levoleucovorin (levoleucovorin)
(Levoleucovorin)Fosun Pharma USA Inc.
Usage: Levoleucovorin injection is indicated for rescue after high-dose methotrexate therapy in osteosarcoma, to reduce toxicity from methotrexate and folic acid antagonist overdosage, and in combination with 5-fluorouracil for palliative treatment of advanced metastatic colorectal cancer. Not for use in pernicious or megaloblastic anemia.
Lonsurf (trifluridine and tipiracil)
(trifluridine and tipiracil)Taiho Pharmaceutical Co., Ltd.
Usage: LONSURF is indicated for adult patients with metastatic colorectal cancer previously treated with specific chemotherapy regimens and therapies, and for those with metastatic gastric or gastroesophageal junction adenocarcinoma who have experienced at least two prior chemotherapy lines, including fluoropyrimidine and platinum-based treatments.